(Q48030104)

7 February 2018

title

Time to progression is dependent on the expression of the tumour suppressor PTEN in ovarian cancer patients. (English)

1 reference

7 February 2018

1 reference

T Schöndorf

1

1 reference

7 February 2018

U-J Göhring

2

1 reference

7 February 2018

G Roth

3

1 reference

7 February 2018

I Middel

4

1 reference

7 February 2018

M Becker

5

1 reference

7 February 2018

N Moser

6

1 reference

7 February 2018

M M Valter

7

1 reference

7 February 2018

M Hoopmann

8

1 reference

7 February 2018

publication date

1 March 2003

1 reference

7 February 2018

European Journal of Clinical Investigation

published in

1 reference

7 February 2018

volume

33

1 reference

7 February 2018

issue

3

1 reference

7 February 2018

page(s)

256-260

1 reference

7 February 2018

PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01116.X

Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01116.X

Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01116.X

Reduced PTEN expression in gastric cancer and in the gastric mucosa of gastric cancer relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01116.X

Epigenetic PTEN silencing in malignant melanomas without PTEN mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01116.X

Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01116.X

Loss of tumor suppressor protein PTEN during renal carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01116.X

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01116.X

Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01116.X

PTEN: The down side of PI 3-kinase signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01116.X

Interaction of cisplatin, paclitaxel and adriamycin with the tumor suppressor PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01116.X

10.1046/J.1365-2362.2003.01116.X

21 January 2018

Identifiers

DOI

1 reference

7 February 2018

release_l5g7uy5yjbfrbfyzquqquvmqge

Fatcat ID

0 references

PubMed ID

12641545

1 reference

7 February 2018